News ‘In Public Interest’: Bharat Biotech Affirms Covaxin Safety Amid AstraZeneca Debate Bharat Biotech said all the studies and safety follow-up activities demonstrated “excellent safety record, without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc” Continue Reading Previous News18 Evening Digest: Amit Shah on ‘Conspiracy To Kill Kejriwal’ Charge; Ticket To Brij Bhushan and Other Top StoriesNext Hoax Bomb Threat: Delhi Cops Contact Interpol For Info On Sender’s IP Address From Russian Agencies More Stories News News18 Afternoon Digest: Shocking Details from Swati Maliwal’s FIR Against Bibhav Kumar And Other Top Stories News Craving Mutton Biryani Early Morning? Visit Kerala’s Famous Vazhiyorakkada Eatery News Checking Tickets To Locking Doors, Duties Of Indian Railways TTE